Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Terazaki

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Oncology Letters|March 31, 2017
Single nucleotide polymorphisms of the haptoglobin gene in non-small cell lung cancer treated with personalized peptide vaccinationKayoko Waki, Teppei Yamada, Koichi Yoshiyama, et al.
Cancer Science|July 21, 2007
Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapyKoichi Azuma, Yoshihiro Komohara, Tetsuro Sasada, et al.
Annals of Thoracic Surgery Short Reports|June 10, 2026
Lung Adenocarcinoma Associated With a Horseshoe Intralobar Lung SequestrationShintaro Yokoyama, Hiromi Oku, Yuichiro Ueta, et al.
Hepatology (Baltimore, Md.)|December 25, 2002
An optimal therapeutic expression level is crucial for suicide gene therapy for hepatic metastatic cancer in miceYasuhiro Terazaki, Shojiro Yano, Kentaro Yuge, et al.
Cancer Science|August 14, 2014
PD-1 expression on peripheral blood T-cell subsets correlates with prognosis in non-small cell lung cancerKayoko Waki, Teppei Yamada, Koichi Yoshiyama, et al.
International Journal of Oncology|June 9, 2005
Adenoviral gene transduction of hepatocyte growth factor elicits inhibitory effects for hepatomaKentaro Yuge, Tomoyuki Takahashi, Satoshi Nagano, et al.
International Journal of Oncology|February 7, 2012
Personalized peptide vaccination in patients with refractory non-small cell lung cancerKoichi Yoshiyama, Yasuhiro Terazaki, Satoko Matsueda, et al.
Human Vaccines & Immunotherapeutics|September 2, 2015
Evaluation of prognostic significance of granulocyte-related factors in cancer patients undergoing personalized peptide vaccinationShinjiro Sakamoto, Munehiro Yoshitomi, Shigeru Yutani, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 4, 2009
Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancerMasaki Kashihara, Koichi Azuma, Akihiko Kawahara, et al.
Clinical Lung Cancer|April 19, 2017
Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung CancerShinjiro Sakamoto, Teppei Yamada, Yasuhiro Terazaki, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Oncology Letters|March 31, 2017
Single nucleotide polymorphisms of the haptoglobin gene in non-small cell lung cancer treated with personalized peptide vaccinationKayoko Waki, Teppei Yamada, Koichi Yoshiyama, et al.
Cancer Science|July 21, 2007
Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapyKoichi Azuma, Yoshihiro Komohara, Tetsuro Sasada, et al.
Annals of Thoracic Surgery Short Reports|June 10, 2026
Lung Adenocarcinoma Associated With a Horseshoe Intralobar Lung SequestrationShintaro Yokoyama, Hiromi Oku, Yuichiro Ueta, et al.
Hepatology (Baltimore, Md.)|December 25, 2002
An optimal therapeutic expression level is crucial for suicide gene therapy for hepatic metastatic cancer in miceYasuhiro Terazaki, Shojiro Yano, Kentaro Yuge, et al.
Cancer Science|August 14, 2014
PD-1 expression on peripheral blood T-cell subsets correlates with prognosis in non-small cell lung cancerKayoko Waki, Teppei Yamada, Koichi Yoshiyama, et al.
International Journal of Oncology|June 9, 2005
Adenoviral gene transduction of hepatocyte growth factor elicits inhibitory effects for hepatomaKentaro Yuge, Tomoyuki Takahashi, Satoshi Nagano, et al.
International Journal of Oncology|February 7, 2012
Personalized peptide vaccination in patients with refractory non-small cell lung cancerKoichi Yoshiyama, Yasuhiro Terazaki, Satoko Matsueda, et al.
Human Vaccines & Immunotherapeutics|September 2, 2015
Evaluation of prognostic significance of granulocyte-related factors in cancer patients undergoing personalized peptide vaccinationShinjiro Sakamoto, Munehiro Yoshitomi, Shigeru Yutani, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 4, 2009
Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancerMasaki Kashihara, Koichi Azuma, Akihiko Kawahara, et al.
Clinical Lung Cancer|April 19, 2017
Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung CancerShinjiro Sakamoto, Teppei Yamada, Yasuhiro Terazaki, et al.
Pageof 3